12LBA Biomarker-driven access to crizotinib in ALK, MET or...

European Journal of Cancer 2015 / 09 Vol. 51

12LBA Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSe Program

Vassal, G., Moro-sibilot, D., Le Deley, M.C., Hoog-labouret, N., Nowak, F., Jimenez, M., Tournigand, C., Houot, R., Malka, D., Aparicio, T., Escudier, B., Ray-coquard, I., Godbert, Y., Taillandier, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(15)30070-8
Date:
September, 2015
File:
PDF, 60 KB
english, 2015
Conversion to is in progress
Conversion to is failed